# Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer

> **NCT04014231** · — · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 160 (estimated)

## Conditions studied

- Malignant Neoplasm

## Interventions

- **PROCEDURE:** Diagnostic Imaging
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT04014231
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-07-21
- **Primary completion:** 2026-05-11
- **Final completion:** 2026-05-11
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04014231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04014231, "Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04014231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*